New Therapies of Liver Diseases |
Autore | Toniutto Pierluigi |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (236 p.) |
Soggetto topico | Public health & preventive medicine |
Soggetto non controllato |
tolvaptan
cirrhotic ascites survival rate furosemide primary biliary cholangitis autoantibodies ursodeoxycholic acid treatment response second line therapy primary biliary cholangitis (PBC) primary sclerosing cholangitis (PSC) clinical trials ursodeoxycholic acid (UDCA) Farnesoid X Receptor (FXR) agonist Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists liver cancer systemic treatment immunotherapy real-world unresectable hepatocellular carcinoma cirrhosis decompensation bleeding varices survival infection alcoholic hepatitis acute-on-chronic liver failure cholangiocarcinoma colorectal cancer metastases hepatocellular carcinoma liver transplantation Milan criteria alpha-fetoprotein solid organ transplantation liver injury immunosuppressant SARS-CoV-2 humoral response vaccination portal-systemic shunt ammonia vigilance HBV HDV antivirals functional cure pharmacology acute-on-chronic liver failure (ACLF) liver transplantation (LT) decompensated cirrhosis portal hypertension ascites non-selective beta-blockers TIPS rifaximin human albumin statins targeted therapy effective hypovolemia anti-mineralocorticoids loop diuretics vaptans |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910566457403321 |
Toniutto Pierluigi
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Targeting the Microbiome for Disease Diagnosis and Therapy : New Frontiers for Personalized Medicine |
Autore | Laterza Lucrezia |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (280 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
Graves-Basedow's diseases
Hashimoto's thyroiditis autoimmunity gut microbiota irritable bowel syndrome microbiota microbiome food components nutrients hematopoietic stem cell transplantation fecal microbiota transplantation aGvHD antibiotic-resistant bacteria cystic fibrosis rabbits intestinal dysbiosis feces microbiome beta-blocker hemodialysis next-generation sequencing propensity score matching methods violin plots random sampling analytical reproducibility fecal matter transplantation data disease subtypes personalized medicine maltodextrin dip test gallstone disease 16S rDNA gene diversity blood biochemical characteristics mesothelioma 16S RNA sequencing species probiotics and gut disease probiotics and acute diverticulitis probiotics and diverticular disease probiotics mechanism of action IgA Nephropathy rifaximin α1KI-CD89Tg mice children intermittent hypoxemia obstructive sleep apnea tonsil weight status oral microbiota rheumatology diseases biomarkers artificial intelligence machine learning rheumatoid arthritis Sjogren's syndrome systemic lupus erythematosus endometrial cancer endometrial microbiome gut microbiome dysbiosis estrogen metabolism estrobolome inflammation antitumour treatment prebiotics probiotics schizophrenia depression anxiety functional genes thymoma genera driver mutation cardiovascular diseases critically ill intestinal permeability recurrent cystitis |
ISBN | 3-0365-5611-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Targeting the Microbiome for Disease Diagnosis and Therapy |
Record Nr. | UNINA-9910637781403321 |
Laterza Lucrezia
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|